Find News

Filter articles

Showing 1 to 10 of 2984 results

Roche loses appeal to block market entry of rival cancer drug

US07-07-2020Muireann Bolger

A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.

EPO launches ‘Fighting coronavirus’ data platform


The European Patent Office has unveiled data sets relating to antiviral vaccines and pharmaceutical therapeutics as part of its new “Fighting coronavirus” platform.

Australian court affirms Mylan patent invalidation


The Federal Court of Australia has upheld a patent victory for Indian generic manufacturer Sun Pharma over Mylan in a dispute over cholesterol drug fenofibrate.

Federal Circuit rules CardioNet patents 'abstract ideas'

03-07-2020Muireann Bolger

US medical technology company CardioNet has lost an appeal at the US Court of Appeals for the Federal Circuit , which found its patents covered abstract concepts and therefore are invalid.

Carpmaels & Ransford promotes Jennifer Antcliff to partner


European law firm Carpmaels & Ransford has promoted Jennifer Antcliff to partner in its dispute resolution team in its London office, bringing the total number of partners in the team to five.

Sandoz fails in Enbrel patent challenge, but Fed Circuit split

US02-07-2020Rory O'Neill

Amgen has won a key patent victory over Sandoz in a dispute over biologic Enbrel.

Glenmark becomes fifth generic to be charged with US antitrust violations

02-07-2020Muireann Bolger

Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Chiesi blocks Japanese drugmaker’s new brand at EU General Court


Japan-based Nitto Pharmaceutical Industries has been blocked from using its ‘Noster’ brand in the EU, in a win for Italian drugmaker Chiesi Farmaceutici.

Labrador drops BioFire suit after COVID-19 revelation


Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

J&J wants $25m over ‘contaminated’ fake medical tools


Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.

Showing 1 to 10 of 2984 results